Diagnosis of combination of serum CA125,HE4 and ROMA in the patients with ovarian cancer
Shijun YANG,Weiping LU,Yunhui ZHENG,Jinhua ZHANG,Manqing LIU,Yongxiang XIA
DOI: https://doi.org/10.3969/j.issn.1672-9455.2016.14.011
2016-01-01
Abstract:Objective To analyze the diagnostic value of serum carbohydrate antigen 125 (CA125) ,human epididymis protein 4 (HE4) and ROMA in patients with ovarian cancer .Methods By Electrochemical luminescence (ECLIA) ,serum HE4 and CA125 of 70 cases diagnosed as ovarian benign disease and 137 cases diagnosed as ovarian cancer were detected before treatment .ROMA were calculated and all the data were analyzed statistically .Results The level of CA125 ,HE4 and ROMA of patients with ovarian cancer were 270 .1 U/mL ,287 .1 pmol/L and 71 .5% respectively ,which of patients with benign ovarian diseases were 25 .4 U/mL , 69 .3 pmol/L ,17 .1% and the level of three indicators in the control group were 14 .5 U/mL ,61 .1 pmol/L and 11 .8% .The differ‐ence of HE4 between the group of benign ovarian diseases and the control group had no statistical significance (P>0 .05) .The sen‐sitivity ,specificity ,positive predictive value ,negative predictive value and coincidence of CA 125 were 77 .4% ,74 .3% ,85 .5% , 62 .6% and 76 .3% respectively ,which of HE4 were 79 .6% ,77 .1% ,87 .2% ,65 .8% and 78 .7% respectively and of ROMA were 89 .8% ,88 .6% ,93 .9% ,81 .6% ,and 89 .4% respectively .The area under the curve (AUC) of CA125 ,HE4 and ROMA were 0 .854 ,0 .936 and 0 .954 respectively .AUC of ROMA was higher than HE4 ,and that of HE4 was also higher than CA125 .The difference of AUC of HE4 before and after menopause was little .Conclusion HE4 could eliminate the interference of ovarian be‐nign disease in the diagnosis of ovarian cancer and specificity of HE4 is higher than CA125 .Combined detection of CA125 ,HE4 and ROM A can improve the positive rate of ovarian cancer .